Antiepileptic drugs:
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Philadelphia [u.a.]
Lippincott Williams & Wilkins
2002
|
| Ausgabe: | 5. ed. |
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | XV, 968 S. Ill., graph. Darst. |
| ISBN: | 0781723213 |
Internformat
MARC
| LEADER | 00000nam a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV014639864 | ||
| 003 | DE-604 | ||
| 005 | 20020823 | ||
| 007 | t | ||
| 008 | 020806s2002 xxuad|| |||| 00||| eng d | ||
| 010 | |a 2002030011 | ||
| 020 | |a 0781723213 |9 0-7817-2321-3 | ||
| 035 | |a (OCoLC)50285309 | ||
| 035 | |a (DE-599)BVBBV014639864 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 044 | |a xxu |c US | ||
| 049 | |a DE-355 |a DE-20 |a DE-29 | ||
| 050 | 0 | |a RC374.C48 | |
| 082 | 0 | |a 616.8/53061 |2 21 | |
| 084 | |a XI 5100 |0 (DE-625)153011:12905 |2 rvk | ||
| 245 | 1 | 0 | |a Antiepileptic drugs |c eds. René H. Levy ... |
| 250 | |a 5. ed. | ||
| 264 | 1 | |a Philadelphia [u.a.] |b Lippincott Williams & Wilkins |c 2002 | |
| 300 | |a XV, 968 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 650 | 4 | |a Anticonvulsivants | |
| 650 | 7 | |a Epilepsie |2 gtt | |
| 650 | 7 | |a Geneesmiddelen |2 gtt | |
| 650 | 4 | |a Épilepsie - Chimiothérapie | |
| 650 | 4 | |a Anticonvulsants | |
| 650 | 4 | |a Anticonvulsants |x pharmacology | |
| 650 | 4 | |a Anticonvulsants |x therapeutic use | |
| 650 | 4 | |a Epilepsy |x Chemotherapy | |
| 650 | 4 | |a Epilepsy |x drug therapy | |
| 650 | 0 | 7 | |a Antiepileptikum |0 (DE-588)4142656-3 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Antiepileptikum |0 (DE-588)4142656-3 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Levy, René H. |e Sonstige |4 oth | |
| 856 | 4 | 2 | |m HBZ Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=009942562&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-009942562 | ||
Datensatz im Suchindex
| _version_ | 1804129405129195520 |
|---|---|
| adam_text | Contributing Authors xi
Preface xvii
SECTION I. GENERAL PRINCIPLES 1
1 Principles of Antiepileptic Drug Action 3
Michael A. Rogawski
2 Neurophysiological Effects of Antiepileptic Drugs
23
Carl W. Bazil and Timothy A. Pedley
3 Discovery and Preclinical Development of
Antiepileptic Drugs 36
H. Steve White, JosiH. Woodhead, Karen S. Wilcox,
James P. Stables, Harvey J. Kupferberg, and
Harold H. Wolf
4 New Antiepileptic Drug Development:
Medical Perspective 49
Jacqueline A. French and Marc A. Dichter
5 Clinical Development of Antiepileptic Drugs:
Industry Perspective 58
Roger J. Porter
6 The Development of Antiepilepsy Drugs:
Regulatory Perspective 66
Russell Katz
7 Antiepileptic Drug Monotherapy in Adults:
Selection and Use in New Onset Epilepsy 72
Richard H. Mattson
8 Combination Therapy and Drug Interactions 96
Emilio Perucca and Rent H. Levy
9 Laboratory Monitoring of Antiepileptic Drugs 103
Svein I. Johannessen and Torbjb rn Tomson
10 Safety Monitoring of Antiepileptic Drugs 112
L. James Willmore
11 Use of Antiepileptic Drugs in Children 119
Olivier Dulac
12 Antiepileptic Drug Use in Wwnen 132
Martha J. Morrell
13 Epilepsy in the Elderly 149
Ilo E. Leppik and James C. Cloyd
14 Treatment of Status Epilepticus 159
Brian K. Alldredge
15 Prevention of Epileptogenesis 169
Asia Pitka nen
SECTION II. BENZODIAZEPINES 177
16 Mechanisms of Action 179
Robert L. Macdonald
17 Chemistry, Biotransformation, and
Pharmacokinetics 187
Gail D. Anderson and John W. Miller
18 Clinical Efficacy and Use in Epilepsy 206
Dieter Schmidt
19 Adverse Effects 215
Roberto Michelucci and Carlo Alberto Tassinari
SECTION III. CARBAMAZEPINE 225
20 Mechanisms of Action 227
Robert L. Macdonald
21 Chemistry, Biotransformation, and
Pharmacokinetics 236
Edoardo Spina
22 Interactions with Other Drugs 247
Colleen J. Warden and Rend H. Levy
23 Clinical EfHcacy and Use in Epilepsy 262
Pierre Loiseau
24 Clinical Efficacy and Use in Other Neurological
Disorders 273
Ettore Beghi
viii Contents
25 Clinical Efficacy and Use in Psychiatric Disorders
278
Michael R. Trimble
26 Adverse Effects 285
Gregory L. Holmes
SECTION IV. FELBAMATE 299
27 Felbamate 301
John M. Pellock, James L. Perhach, and
R. Duane Sofia
SECTION V. GABAPENTIN 319 28 Mechanisms of Action 321
Charles P. Taylor
29 Chemistry, Biotransformation, Pharmacokinetics,
and Interactions 335
Frank J. E. Vajda
30 Clinical Use 340
Anthony G. Marson and David W. Chadwick
31 Clinical Efficacy and Use in Other Neurological
Disorders 344
Bernd Schmidt
32 Clinical Efficacy and Use in Psychiatric Disorders
349
John H. Greist
33 Adverse Effects 354
R. Eugene Ramsay and Flavia M. Pryor
SECTION VI. LAMOTRIGINE 361 ~
34 Mechanisms of Action 363
Michael]. Leach, Andrew D. Randall,
Alessandro Stefani, andAtticus H. Hainsworth
35 Chemistry, Biotransformation, and
Pharmacokinetics 370
Maurice Dickins and Chao Chen
36 Interactions with Other Drugs 380
William R. Garnett
37 Clinical Efficacy and Use in Epilepsy 389
Linda J. Stephen and Martin J. Brodie
38 Efficacy and Use in Nonepileptic Disorders 403
Melvin D. Shelton and Joseph R. Calabrese
39 Adverse Effects 408
Francesco Pisani and Alan Richens
SECTION VII. LEVETIRACETAM 417 40 Mechanisms of Action 419
Doru Georg Margineanu and Henrik Klitgaard
41 Chemistry, Biotransformation, Pharmacokinetics,
and Drug Interactions 428
Philip N. Patsalos
42 Clinical Use 433
Ilo E. Leppik
43 Adverse Experiences 442
Victor Biton
SECTION VIII. OXCARBAZEPINE 449 44 Mechanisms of Action 451
Michael J. McLean
45 Chemistry, Biotransformation, and
Pharmacokinetics 459
Meir Bialer
46 Interactions with Other Drugs 466
Fiorenzo Albani, Roberto Riva, andAgostino Baruzzi
47 Clinical Efficacy and Use in Epilepsy 470
Steven C. Schachter
48 Clinical Efficacy and Use in Psychiatric Disorders
476
Michael R. Trimble
49 Adverse Effects 479
Giinter Kramer
SECTION IX. PHENOBARBITAL AND OTHER
BARBITURATES 487 50 Mechanisms of Action 489
Richard W Olsen
51 Chemistry, Biotransformation, and
Pharmacokinetics 496
Gail D. Anderson
52 Interactions with Other Drugs 504
/. Steven Leeder
53 Clinical Efficacy and Use in Epilepsy 514
Michel Baulac
54 Clinical Efficacy and Use in Nonepileptic
Disorders 522
Ettore Beghi
55 Adverse Effects 528
Michel Baulac, Joyce A. Cramer, and
Richard H. Mattson
56 Methylphenobarbital 541
Mervyn J. Eadie and Wayne D. Hooper
SECTION X. PHENYTOIN AND OTHER
HYPANTOINS 549 57 Mechanisms of Action 551
Robert]. DeLorenza and David A. Sun
58 Chemistry and Biotransformation 565
Thomas R. Browne and Barbara LeDuc
59 Interactions with Other Drugs 581
Isabelle Ragueneau Majlessi, Manoj Bajpai,
and Rene H. Levy
60 Clinical Efficacy and Use in Epilepsy 591
B. Joe Wilder and Joseph Bruni
61 Clinical Efficacy and Use in Other Neurological
Disorders 597
Ettore Beghi
62 Clinical Efficacy and Use in Psychiatric Disorders
600
Francesco Monaco and Marco Mula
63 Adverse Effects 605
Joseph Bruni
64 Fosphenytoin 611
Flavia M. Pryor and R. Eugene Ramsay
SECTION XI. PRIMIDONE 619
65 Primidone 621
Richard W. Fincham and Dorothy D. Schottelius
SECTION XII. SUCCINIMIDES 637
66 Mechanisms of Action 639
Katherine D. Holland and James A. Ferrendelli
67 Ethosuximide: Chemistry, Biotransformation,
Pharmacokinetics, and Drug Interactions 646
Francesco Pisani, Emilio Perucca, and Meir Bialer
68 Clinical Efficacy and Use in Epilepsy 652
Allan L. Sherwin
69 Adverse Effects 658
Tracy A. Glauser
Contents ix
70 Methsuximide 665
Thomas R. Browne
SECTION XIII. TIAGABINE 673 ~
71 Mechanisms of Action 675
William ]. Giardina
72 Chemistry, Biotransformation, and
Pharmacokinetics 681
Kenneth W. Sommerville and Stephen D. Collins
73 Drug Interactions 691
Kenneth W. Sommerville
74 Clinical Efficacy and Use in Epilepsy 698
Reetta Kalvidinen
75 Clinical Efficacy and Use in Nonepileptic
Disorders 705
Kenneth W. Sommerville
76 Adverse Effects 711
Steven C. Schachter
SECTION XIV. TOPIRAMATE 717 77 Mechanisms of Action 719
H. Steve White
78 Chemistry, Biotransformation, and
Pharmacokinetics 727
Dennis R. Doose and Anthony J. Streeter
79 Drug Interactions 735
Barry E. Gidal
80 Clinical Efficacy and Use in Epilepsy 740
Michael D. Privitera and Roy E. Twyman
81 Clinical Efficacy and Use in Nonepileptic
Disorders 753
Marc Kamin
82 Adverse Effects 760
Rajesh C. Sachdeo and Roopal M. Karia
SECTION XV. VALPROIC ACID 765 83 Mechanisms of Action 767
Wolfgang Loscher
84 Chemistry, Biotransformation, and
Pharmacokinetics 780
Rene1 H. Levy, Danny D. Shen, Frank S. Abbott,
Wayne Riggs, and Houda Hachad
X Contents
85 Drug Interactions 801
Richard D. Scheyer
86 Clinical Efficacy and Use in Epilepsy 808
Blaise E D. Bourgeois
87 Clinical Efficacy and Use in Other Neurological
Disorders 818
Stephen D. Silberstein
88 Clinical Efficacy and Use in Psychiatric Disorders
828
Alan C. Swann
89 Adverse Effects 837
Pierre Genton and Philippe Gelisse
SECTION XVI. VIGABATRIN 853
90 Vigabatrin 855
Elinor Ben Menachem
SECTION XVII. ZONISAMIDE 865 91 Mechanisms of Action 867
Robert L. Macdonald
92 Chemistry, Biotransformation, and
Pharmacokinetics 873
Jaymin Shah, Kent Shellenberger, Daniel M. Canafax
93 Drug Interactions 880
Gary G. Mather and Jaymin Shah
94 Clinical Efficacy and Use in Epilepsy 885
Masakazu Seino and Buichi Fujitani
95 Adverse Effects 892
Byung In Lee
SECTION XVIII. DRUGS IN DEVELOPMENT
899 96 Pregabalin 901
Elinor Ben Menachem and Alan R Kugler
97 Rufinamide 906
Mary Ann Karolchyk and Dieter Schmidt
98 Drugs in Early Clinical Development 913
Emilio Perucca and Harvey J. Kupferberg
Subject Index 929
|
| any_adam_object | 1 |
| building | Verbundindex |
| bvnumber | BV014639864 |
| callnumber-first | R - Medicine |
| callnumber-label | RC374 |
| callnumber-raw | RC374.C48 |
| callnumber-search | RC374.C48 |
| callnumber-sort | RC 3374 C48 |
| callnumber-subject | RC - Internal Medicine |
| classification_rvk | XI 5100 |
| ctrlnum | (OCoLC)50285309 (DE-599)BVBBV014639864 |
| dewey-full | 616.8/53061 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.8/53061 |
| dewey-search | 616.8/53061 |
| dewey-sort | 3616.8 553061 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| edition | 5. ed. |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01662nam a2200481zc 4500</leader><controlfield tag="001">BV014639864</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20020823 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">020806s2002 xxuad|| |||| 00||| eng d</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="a">2002030011</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0781723213</subfield><subfield code="9">0-7817-2321-3</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)50285309</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV014639864</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">xxu</subfield><subfield code="c">US</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-20</subfield><subfield code="a">DE-29</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC374.C48</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.8/53061</subfield><subfield code="2">21</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XI 5100</subfield><subfield code="0">(DE-625)153011:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Antiepileptic drugs</subfield><subfield code="c">eds. René H. Levy ...</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">5. ed.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Philadelphia [u.a.]</subfield><subfield code="b">Lippincott Williams & Wilkins</subfield><subfield code="c">2002</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XV, 968 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Anticonvulsivants</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Epilepsie</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Geneesmiddelen</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Épilepsie - Chimiothérapie</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Anticonvulsants</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Anticonvulsants</subfield><subfield code="x">pharmacology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Anticonvulsants</subfield><subfield code="x">therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Epilepsy</subfield><subfield code="x">Chemotherapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Epilepsy</subfield><subfield code="x">drug therapy</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Antiepileptikum</subfield><subfield code="0">(DE-588)4142656-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Antiepileptikum</subfield><subfield code="0">(DE-588)4142656-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Levy, René H.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=009942562&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-009942562</subfield></datafield></record></collection> |
| id | DE-604.BV014639864 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T19:04:37Z |
| institution | BVB |
| isbn | 0781723213 |
| language | English |
| lccn | 2002030011 |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-009942562 |
| oclc_num | 50285309 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR DE-20 DE-29 |
| owner_facet | DE-355 DE-BY-UBR DE-20 DE-29 |
| physical | XV, 968 S. Ill., graph. Darst. |
| publishDate | 2002 |
| publishDateSearch | 2002 |
| publishDateSort | 2002 |
| publisher | Lippincott Williams & Wilkins |
| record_format | marc |
| spelling | Antiepileptic drugs eds. René H. Levy ... 5. ed. Philadelphia [u.a.] Lippincott Williams & Wilkins 2002 XV, 968 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Anticonvulsivants Epilepsie gtt Geneesmiddelen gtt Épilepsie - Chimiothérapie Anticonvulsants Anticonvulsants pharmacology Anticonvulsants therapeutic use Epilepsy Chemotherapy Epilepsy drug therapy Antiepileptikum (DE-588)4142656-3 gnd rswk-swf Antiepileptikum (DE-588)4142656-3 s DE-604 Levy, René H. Sonstige oth HBZ Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=009942562&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Antiepileptic drugs Anticonvulsivants Epilepsie gtt Geneesmiddelen gtt Épilepsie - Chimiothérapie Anticonvulsants Anticonvulsants pharmacology Anticonvulsants therapeutic use Epilepsy Chemotherapy Epilepsy drug therapy Antiepileptikum (DE-588)4142656-3 gnd |
| subject_GND | (DE-588)4142656-3 |
| title | Antiepileptic drugs |
| title_auth | Antiepileptic drugs |
| title_exact_search | Antiepileptic drugs |
| title_full | Antiepileptic drugs eds. René H. Levy ... |
| title_fullStr | Antiepileptic drugs eds. René H. Levy ... |
| title_full_unstemmed | Antiepileptic drugs eds. René H. Levy ... |
| title_short | Antiepileptic drugs |
| title_sort | antiepileptic drugs |
| topic | Anticonvulsivants Epilepsie gtt Geneesmiddelen gtt Épilepsie - Chimiothérapie Anticonvulsants Anticonvulsants pharmacology Anticonvulsants therapeutic use Epilepsy Chemotherapy Epilepsy drug therapy Antiepileptikum (DE-588)4142656-3 gnd |
| topic_facet | Anticonvulsivants Epilepsie Geneesmiddelen Épilepsie - Chimiothérapie Anticonvulsants Anticonvulsants pharmacology Anticonvulsants therapeutic use Epilepsy Chemotherapy Epilepsy drug therapy Antiepileptikum |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=009942562&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT levyreneh antiepilepticdrugs |